Financhill
Back

Altimmune Stock Predictions

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 7.6% based on the past 19 years of stock performance.
  • Altimmune has risen higher in 7 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.84%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $5.81. The Score for ALT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • ALT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 7.6% based on the past 19 years of stock performance.

Altimmune Stock Rating

Sell
31
Altimmune (ALT) is a Sell

Is Altimmune overpriced?

  • Altimmune has risen higher in 7 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.84%

Altimmune Stock Price History

Is ALT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
11.16
52-Week Low:
5.14

Prediction Charts

Market Cap:
447.4M
Price in USD:
5.81
Volume:
2M
Beta:
1.18

Technical Analysis

SMA50:
6.41
SMA100:
7.21
SMA200:
6.95
52-Wk Change:
-36.22%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 5.81 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-3 6.71 5.98 6.71 5.93
Mar-4 5.82 5.96 6.07 5.50
Mar-5 5.94 5.71 6.09 5.71
Mar-6 5.58 5.57 5.66 5.41
Mar-7 5.53 5.55 5.64 5.46
Mar-11 5.38 5.25 5.45 5.15
Mar-12 5.41 5.55 5.61 5.39
Mar-13 5.46 5.20 5.62 5.14
Mar-14 5.39 5.90 6.05 5.36
Mar-17 5.92 5.97 6.01 5.45
Mar-18 5.87 5.61 5.89 5.48
Mar-19 5.60 5.81 5.88 5.55
Mar-20 5.74 5.78 5.87 5.64
Mar-21 5.65 5.81 5.87 5.60

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.16 per share, and a decrease next year of $0.48 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.